← Leaderboards
Ganesh A Thakur
Northeastern University
$3,733,453
Attributed
$5,358,864
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,358,864 · 5
By mechanism
R01$4,968,864 · 4
R03$390,000 · 1
Top collaborators
- Christie D Fowler2 shared
- Ayman K. Hamouda2 shared
- Andrea Grace Hohmann1 shared
- Paul Whiteaker1 shared
Most similar at Northeastern University
Same institution · by research overlap
- Makriyannis Alexandros$2,110,960
- Spyros P Nikas$2,692,748
Others in their field
Top investigators on “Ligands”
- John Damon Chodera · Sloan-Kettering Inst Can Research$39,009,297
- Keith W Miller · Massachusetts General Hospital$35,506,092
- Ian A Wilson · Scripps Research Institute, The$35,392,112
- Bryan L Roth · Univ Of North Carolina Chapel Hill$32,442,555
- Edward Franklin Plow · Cleveland Clinic Foundation$32,215,714
- Helen M Berman · Rutgers University New Brunswick$32,076,400
Research focus
LigandsPharmaceutical PreparationsDesignSeriesLeadIn VivoPropertyExhibitsFutureDrug KineticsReceptor SignalingMediatingSolubilityMedicalAgonistAffinityIn VitroAnalogEndocannabinoidsBiological AvailabilityAdverse EffectsSmall MoleculeCellsPermeability
Grant awards (11)
Selective Positive Allosteric Modulators of a4b2 Nicotinic Receptors$700,679
R01 · FY2025 · DA · contact PI
Development of non-opioid, non-addictive analgesics for treating neuropathic pain$675,107
R01 · FY2025 · NS · contact PI
Selective Probes for Alpha9* Nicotinic Acetylcholine Receptors$650,079
R01 · FY2025 · NS · contact PI
Selective Positive Allosteric Modulators of a4b2 Nicotinic Receptors$743,548
R01 · FY2024 · DA · contact PI
A Novel Pharmacotherapy for Glaucoma$422,670
R01 · FY2018 · EY · contact PI
A Novel Pharmacotherapy for Glaucoma$422,670
R01 · FY2017 · EY · contact PI
A Novel Pharmacotherapy for Glaucoma$422,670
R01 · FY2016 · EY · contact PI
A Novel Pharmacotherapy for Glaucoma$414,516
R01 · FY2015 · EY · contact PI
A Novel Pharmacotherapy for Glaucoma$516,925
R01 · FY2014 · EY · contact PI
Allosteric Modulators of CB1 Cannabinoid Receptor$195,000
R03 · FY2010 · DA · contact PI
Allosteric Modulators of CB1 Cannabinoid Receptor$195,000
R03 · FY2009 · DA · contact PI